Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to -$71.0 million.

  • Bristol Myers Squibb's Change in Inventory rose 5942.86% to -$71.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $184.0 million, marking a year-over-year decrease of 6213.99%. This contributed to the annual value of $184.0 million for FY2025, which is 6213.99% down from last year.
  • As of Q4 2025, Bristol Myers Squibb's Change in Inventory stood at -$71.0 million, which was up 5942.86% from $90.0 million recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Change in Inventory peaked at $282.0 million during Q1 2023, and registered a low of -$175.0 million during Q4 2024.
  • For the 5-year period, Bristol Myers Squibb's Change in Inventory averaged around $73.8 million, with its median value being $28.5 million (2022).
  • As far as peak fluctuations go, Bristol Myers Squibb's Change in Inventory soared by 2830000.0% in 2023, and later tumbled by 18883.25% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Change in Inventory (Quarter) stood at $128.0 million in 2021, then crashed by 67.97% to $41.0 million in 2022, then surged by 380.49% to $197.0 million in 2023, then crashed by 188.83% to -$175.0 million in 2024, then surged by 59.43% to -$71.0 million in 2025.
  • Its last three reported values are -$71.0 million in Q4 2025, $90.0 million for Q3 2025, and -$4.0 million during Q2 2025.